Anshul Bhalchandra Parulkar, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coronary Vessel Anomalies | 1 | 2020 | 317 | 0.560 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 1928 | 0.380 |
Why?
|
| Coronary Vessels | 2 | 2020 | 3115 | 0.380 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 2129 | 0.330 |
Why?
|
| Ventricular Function, Left | 2 | 2021 | 3844 | 0.310 |
Why?
|
| Cardiac Tamponade | 1 | 2024 | 172 | 0.220 |
Why?
|
| Endocarditis, Bacterial | 1 | 2024 | 446 | 0.180 |
Why?
|
| Replantation | 1 | 2020 | 140 | 0.160 |
Why?
|
| Atrial Appendage | 1 | 2021 | 292 | 0.140 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2017 | 279 | 0.130 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 327 | 0.120 |
Why?
|
| Arteriosclerosis | 1 | 2016 | 1054 | 0.100 |
Why?
|
| Atrial Fibrillation | 2 | 2021 | 5161 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 1334 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 1602 | 0.080 |
Why?
|
| Aorta | 1 | 2016 | 2037 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 3601 | 0.080 |
Why?
|
| Coronary Angiography | 1 | 2020 | 4558 | 0.080 |
Why?
|
| Catheter Ablation | 1 | 2020 | 2734 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2020 | 6389 | 0.070 |
Why?
|
| Patient Readmission | 1 | 2020 | 3310 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 7346 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2020 | 9202 | 0.060 |
Why?
|
| Ciprofloxacin | 1 | 2024 | 311 | 0.050 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2024 | 239 | 0.050 |
Why?
|
| Pericardial Effusion | 1 | 2024 | 245 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 6625 | 0.040 |
Why?
|
| Collateral Circulation | 1 | 2017 | 282 | 0.030 |
Why?
|
| Heart Failure | 1 | 2020 | 11784 | 0.030 |
Why?
|
| Mitral Valve | 1 | 2024 | 1483 | 0.030 |
Why?
|
| Tunica Intima | 1 | 2016 | 457 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15590 | 0.030 |
Why?
|
| Male | 5 | 2024 | 356852 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 682 | 0.030 |
Why?
|
| Echocardiography | 1 | 2024 | 4958 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2017 | 1579 | 0.020 |
Why?
|
| Humans | 7 | 2024 | 756111 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 218302 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2016 | 3123 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2016 | 4665 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 6118 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2021 | 5471 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2962 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2016 | 3203 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2788 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 58608 | 0.020 |
Why?
|
| Aged | 3 | 2024 | 167585 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 4342 | 0.020 |
Why?
|
| Middle Aged | 3 | 2024 | 218357 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2021 | 64582 | 0.010 |
Why?
|
| Quality of Life | 1 | 2020 | 13215 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 21780 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 167069 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2017 | 23254 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 79746 | 0.010 |
Why?
|
| United States | 1 | 2020 | 71909 | 0.010 |
Why?
|
| Female | 2 | 2021 | 388229 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 80709 | 0.010 |
Why?
|